Vident Investment Advisory LLC lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 2.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,531 shares of the healthcare conglomerate’s stock after selling 426 shares during the quarter. Vident Investment Advisory LLC’s holdings in UnitedHealth Group were worth $4,792,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of UNH. FMR LLC raised its stake in shares of UnitedHealth Group by 5.1% in the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after purchasing an additional 2,981,233 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Jennison Associates LLC raised its stake in shares of UnitedHealth Group by 12.0% in the 2nd quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock valued at $1,623,329,000 after purchasing an additional 710,745 shares in the last quarter. Summit Trail Advisors LLC raised its stake in shares of UnitedHealth Group by 19,286.4% in the 1st quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock valued at $6,228,000 after purchasing an additional 6,195,939 shares in the last quarter. Finally, Morgan Stanley raised its stake in shares of UnitedHealth Group by 5.2% in the 2nd quarter. Morgan Stanley now owns 5,498,557 shares of the healthcare conglomerate’s stock valued at $1,349,017,000 after purchasing an additional 269,652 shares in the last quarter. Hedge funds and other institutional investors own 85.30% of the company’s stock.

In related news, Director Kenneth Irwin Shine sold 177 shares of the business’s stock in a transaction dated Wednesday, July 18th. The shares were sold at an average price of $255.72, for a total transaction of $45,262.44. Following the completion of the sale, the director now owns 29,053 shares of the company’s stock, valued at approximately $7,429,433.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Steven H. Nelson sold 26,033 shares of the company’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 94,745 shares of company stock valued at $24,995,290. Insiders own 0.87% of the company’s stock.

Shares of NYSE:UNH opened at $263.51 on Wednesday. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.63. UnitedHealth Group Inc has a fifty-two week low of $186.00 and a fifty-two week high of $271.16. The stock has a market cap of $256.66 billion, a P/E ratio of 26.17, a price-to-earnings-growth ratio of 1.59 and a beta of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business had revenue of $56.09 billion during the quarter, compared to the consensus estimate of $56.10 billion. During the same quarter in the prior year, the firm earned $2.46 EPS. The company’s revenue for the quarter was up 12.1% compared to the same quarter last year. equities analysts expect that UnitedHealth Group Inc will post 12.72 earnings per share for the current fiscal year.

UnitedHealth Group declared that its board has approved a stock repurchase program on Wednesday, June 6th that permits the company to repurchase 100,000,000 shares. This repurchase authorization permits the healthcare conglomerate to reacquire shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 18th. Investors of record on Friday, September 7th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date was Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.

A number of equities research analysts have recently issued reports on UNH shares. Morgan Stanley upped their target price on shares of UnitedHealth Group from $277.00 to $278.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Citigroup upped their target price on shares of UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $282.00 to $284.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Goldman Sachs Group restated a “buy” rating and issued a $277.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 17th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 target price on the stock in a research note on Sunday, July 15th. Two investment analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $275.87.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Google Finance

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.